1287906

Reese Pharmaceutical Company — FEI 1518939

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cleveland, OH (United States)